<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9925106</article-id>
    <article-id pub-id-type="pmid">36727489</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btad071</article-id>
    <article-id pub-id-type="publisher-id">btad071</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Paper</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Systems Biology</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>WMDS.net: a network control framework for identifying key players in transcriptome programs</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Cheng</surname>
          <given-names>Xiang</given-names>
        </name>
        <aff><institution>Department of Gynecologic Oncology, Women’s Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine</institution>, Hangzhou 310006, <country country="CN">China</country></aff>
        <aff><institution>Institute of Bioinformatics, Zhejiang University</institution>, Hangzhou 310058, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Amanullah</surname>
          <given-names>Md</given-names>
        </name>
        <aff><institution>Institute of Bioinformatics, Zhejiang University</institution>, Hangzhou 310058, <country country="CN">China</country></aff>
        <aff><institution>Department of Respiratory Medicine, Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province, Sir Run Run Shaw Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine</institution>, Hangzhou 310016, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Weigang</given-names>
        </name>
        <aff><institution>Department of Respiratory Medicine, Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province, Sir Run Run Shaw Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine</institution>, Hangzhou 310016, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Yi</given-names>
        </name>
        <aff><institution>Institute of Bioinformatics, Zhejiang University</institution>, Hangzhou 310058, <country country="CN">China</country></aff>
        <aff><institution>Department of Respiratory Medicine, Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province, Sir Run Run Shaw Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine</institution>, Hangzhou 310016, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Pan</surname>
          <given-names>Xiaoqing</given-names>
        </name>
        <aff><institution>Department of Mathematics, Shanghai Normal University</institution>, Xuhui 200234, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Honghe</given-names>
        </name>
        <aff><institution>Department of Pathology, Research Unit of Intelligence Classification of Tumor Pathology and Precision Therapy, Chinese Academy of Medical Sciences, Zhejiang University School of Medicine</institution>, Hangzhou 310058, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xu</surname>
          <given-names>Haiming</given-names>
        </name>
        <aff><institution>Institute of Bioinformatics, Zhejiang University</institution>, Hangzhou 310058, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8386-8416</contrib-id>
        <name>
          <surname>Liu</surname>
          <given-names>Pengyuan</given-names>
        </name>
        <aff><institution>Department of Gynecologic Oncology, Women’s Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine</institution>, Hangzhou 310006, <country country="CN">China</country></aff>
        <aff><institution>Department of Physiology, Center of Systems Molecular Medicine, Medical College of Wisconsin</institution>, Milwaukee, WI 53226, <country country="US">USA</country></aff>
        <aff><institution>Cancer Center, Zhejiang University</institution>, Hangzhou 310029, <country country="CN">China</country></aff>
        <xref rid="btad071-cor1" ref-type="corresp"/>
        <!--pyliu@zju.edu.cn-->
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5004-4656</contrib-id>
        <name>
          <surname>Lu</surname>
          <given-names>Yan</given-names>
        </name>
        <aff><institution>Department of Gynecologic Oncology, Women’s Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine</institution>, Hangzhou 310006, <country country="CN">China</country></aff>
        <aff><institution>Institute of Bioinformatics, Zhejiang University</institution>, Hangzhou 310058, <country country="CN">China</country></aff>
        <aff><institution>Cancer Center, Zhejiang University</institution>, Hangzhou 310029, <country country="CN">China</country></aff>
        <xref rid="btad071-cor1" ref-type="corresp"/>
        <!--yanlu76@zju.edu.cn-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Cowen</surname>
          <given-names>Lenore</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btad071-cor1">To whom correspondence should be addressed. Email: <email>pyliu@zju.edu.cn</email> or <email>yanlu76@zju.edu.cn</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <month>2</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2023-02-02">
      <day>02</day>
      <month>2</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>02</day>
      <month>2</month>
      <year>2023</year>
    </pub-date>
    <volume>39</volume>
    <issue>2</issue>
    <elocation-id>btad071</elocation-id>
    <history>
      <date date-type="received">
        <day>29</day>
        <month>6</month>
        <year>2022</year>
      </date>
      <date date-type="rev-recd">
        <day>16</day>
        <month>1</month>
        <year>2023</year>
      </date>
      <date date-type="editorial-decision">
        <day>30</day>
        <month>1</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>01</day>
        <month>2</month>
        <year>2023</year>
      </date>
      <date date-type="corrected-typeset">
        <day>13</day>
        <month>2</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btad071.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Motivation</title>
        <p>Mammalian cells can be transcriptionally reprogramed to other cellular phenotypes. Controllability of such complex transitions in transcriptional networks underlying cellular phenotypes is an inherent biological characteristic. This network controllability can be interpreted by operating a few key regulators to guide the transcriptional program from one state to another. Finding the key regulators in the transcriptional program can provide key insights into the network state transition underlying cellular phenotypes.</p>
      </sec>
      <sec id="s2">
        <title>Results</title>
        <p>To address this challenge, here, we proposed to identify the key regulators in the transcriptional co-expression network as a minimum dominating set (MDS) of driver nodes that can fully control the network state transition. Based on the theory of structural controllability, we developed a weighted MDS network model (WMDS.net) to find the driver nodes of differential gene co-expression networks. The weight of WMDS.net integrates the degree of nodes in the network and the significance of gene co-expression difference between two physiological states into the measurement of node controllability of the transcriptional network. To confirm its validity, we applied WMDS.net to the discovery of cancer driver genes in RNA-seq datasets from The Cancer Genome Atlas. WMDS.net is powerful among various cancer datasets and outperformed the other top-tier tools with a better balance between precision and recall.</p>
      </sec>
      <sec id="s3">
        <title>Availability and implementation</title>
        <p><ext-link xlink:href="https://github.com/chaofen123/DriverWMDS" ext-link-type="uri">https://github.com/chaofen123/WMDS.net</ext-link>.</p>
      </sec>
      <sec id="s5">
        <title>Supplementary information</title>
        <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Key Research &amp; Development Program of Zhejiang Province</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2021C03126</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>82072857</award-id>
        <award-id>81871864</award-id>
        <award-id>92253203</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>CAMS Innovation Fund for Medical Sciences</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2019-I2M-5-044</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Medical Health Science and Technology Key Project of Zhejiang Provincial Health Commission</institution>
          </institution-wrap>
        </funding-source>
        <award-id>WKJ-ZJ-2007</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Key Program of Zhejiang Provincial Natural Science Foundation</institution>
          </institution-wrap>
        </funding-source>
        <award-id>LZ20H160001</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Institutes of Health</institution>
            <institution-id institution-id-type="DOI">10.13039/100000002</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>HL149620</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="9"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>In biological processes, genes and proteins rarely act alone, they rather act in concert and in parallel to form a complex network-like interactome (<xref rid="btad071-B4" ref-type="bibr">Barabasi <italic toggle="yes">et al.</italic>, 2011</xref>). The irregular perturbation of this interactome can lead to the pathological state, such as cancer (<xref rid="btad071-B25" ref-type="bibr">Grechkin <italic toggle="yes">et al.</italic>, 2016</xref>). Transcriptional co-expression network is one of key interactomes in eukaryote, where the nodes represent genes and edges between genes correspond to significant interactive relations (<xref rid="btad071-B3" ref-type="bibr">Barabasi and Albert, 1999</xref>). This type of network can be constructed from genome-wide expression profiling that is carried out by microarray, RNA-seq and other high-throughput technologies (<xref rid="btad071-B6" ref-type="bibr">Basso <italic toggle="yes">et al.</italic>, 2005</xref>; <xref rid="btad071-B16" ref-type="bibr">Delgado and Gomez-Vela, 2019</xref>; <xref rid="btad071-B42" ref-type="bibr">Kuzmanovski <italic toggle="yes">et al.</italic>, 2018</xref>). It represents the concerted gene regulation programs through statistical inference of co-expression patterns (<xref rid="btad071-B13" ref-type="bibr">de Anda-Jáuregui <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btad071-B43" ref-type="bibr">Langfelder and Horvath, 2008</xref>). The study of transcriptional co-expression network can help to understand the key cellular behavior from a systems perspective (<xref rid="btad071-B18" ref-type="bibr">Eisenberg <italic toggle="yes">et al.</italic>, 2000</xref>).</p>
    <p>During different developmental stages, the transition of different cell states, or the progression from a normal state to a disease state, living cells often undergo drastic rewiring of the transcription co-expression networks (<xref rid="btad071-B20" ref-type="bibr">Flintoft, 2004</xref>). Notably, the rewiring of transcriptional networks in living cells not only involves in the destruction of existing connectivity between genes, but also the reconstruction of new connectivity between genes. Several methods have been developed to identify differential co-expression networks under different conditions, such as developmental stages and disease status (<xref rid="btad071-B4" ref-type="bibr">Barabasi <italic toggle="yes">et al.</italic>, 2011</xref>; <xref rid="btad071-B36" ref-type="bibr">Ideker and Krogan, 2012</xref>). However, most of these previous methods focused on finding co-expression patterns varying between different conditions (<xref rid="btad071-B14" ref-type="bibr">de la Fuente, 2010</xref>; <xref rid="btad071-B29" ref-type="bibr">Gustafsson <italic toggle="yes">et al.</italic>, 2014</xref>; <xref rid="btad071-B49" ref-type="bibr">Lu <italic toggle="yes">et al.</italic>, 2007</xref>). There are very few methods to detect which key players in the transcriptional network drive cells from one state to another.</p>
    <p>Mammalian cells can be transcriptionally reprogramed to other cellular phenotypes (<xref rid="btad071-B35" ref-type="bibr">Huang <italic toggle="yes">et al.</italic>, 2011</xref>; <xref rid="btad071-B37" ref-type="bibr">Ieda <italic toggle="yes">et al.</italic>, 2010</xref>; <xref rid="btad071-B60" ref-type="bibr">Szabo <italic toggle="yes">et al.</italic>, 2010</xref>; <xref rid="btad071-B61" ref-type="bibr">Takahashi and Yamanaka, 2006</xref>; <xref rid="btad071-B66" ref-type="bibr">Vierbuchen <italic toggle="yes">et al.</italic>, 2010</xref>). Controllability of such complex transitions in transcriptional networks underlying cellular phenotypes seems to be an inherent biological characteristic and is used to develop new disease models, tissue engineering and stem cell therapies (<xref rid="btad071-B51" ref-type="bibr">Muller and Schuppert, 2011</xref>). According to the structural controllability theory, the ability to steer a complex network from any initial state to any desired state can be measured by the minimum number of driver nodes required to input external signals, thereby completely controlling the whole network (<xref rid="btad071-B33" ref-type="bibr">Hu <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btad071-B47" ref-type="bibr">Liu <italic toggle="yes">et al.</italic>, 2011</xref>). The maximum matching approach (<xref rid="btad071-B47" ref-type="bibr">Liu <italic toggle="yes">et al.</italic>, 2011</xref>) has been used to identify driver nodes in directed networks, while the minimum dominating set (MDS) (<xref rid="btad071-B52" ref-type="bibr">Nacher and Akutsu, 2012</xref>) was also recently proposed to identify driver nodes in undirected networks. When each edge in a network is bi-directional, and each node in the MDS can individually control all of its outgoing links, this bi-directional network is structurally controllable by selecting the nodes in the MDS as driver nodes. In this case, this MDS can be regarded as a maximal matching. To investigate transcriptional regulation, we proposed to identify the key players in the transcriptional network as a MDS of driver nodes that can fully control the network state transition. However, different MDSs will be predicted in the same network because the MDS model is not unique. Therefore, we employed a weighted minimum dominating set (WMDS) network model (WMDS.net) to determine the driver nodes of network. The weight of WMDS.net integrates the degree of nodes in the network and the significance of gene co-expression difference between two states into the measurement of node controllability of the transcriptional network.</p>
    <p>To illustrate the utility of WMDS.net, we applied it to the discovery of cancer driver genes in RNA-seq data from The Cancer Genome Atlas (TCGA). Driver genes modify transcriptional programs in the process of tumorigenesis and cancer progression, driving and sustaining a biological system from healthy state to disease state, whereas most of altered genes detected in cancer genomics studies are passengers that are irrelevant to tumor development and progression (<xref rid="btad071-B26" ref-type="bibr">Greenman <italic toggle="yes">et al.</italic>, 2007</xref>; <xref rid="btad071-B30" ref-type="bibr">Han <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btad071-B34" ref-type="bibr">Hua <italic toggle="yes">et al.</italic>, 2013</xref>). In this application, we aimed to identify critical nodes of the transcriptional co-expression network constructed from RNA-seq data of tumor and adjacent normal tissues, which guide cells from normal to hyper-proliferative state. We further compared our method with other 11 top-tier driver gene detection methods on 14 TCGA datasets (<xref rid="btad071-B5" ref-type="bibr">Bashashati <italic toggle="yes">et al.</italic>, 2012</xref>; <xref rid="btad071-B24" ref-type="bibr">Gonzalez-Perez and Lopez-Bigas, 2012</xref>; <xref rid="btad071-B27" ref-type="bibr">Guo <italic toggle="yes">et al.</italic>, 2018</xref>, <xref rid="btad071-B28" ref-type="bibr">2019</xref>; <xref rid="btad071-B30" ref-type="bibr">Han <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btad071-B32" ref-type="bibr">Hou and Ma, 2014</xref>; <xref rid="btad071-B34" ref-type="bibr">Hua <italic toggle="yes">et al.</italic>, 2013</xref>; <xref rid="btad071-B38" ref-type="bibr">Jia <italic toggle="yes">et al.</italic>, 2014</xref>; <xref rid="btad071-B44" ref-type="bibr">Lawrence <italic toggle="yes">et al.</italic>, 2013</xref>; <xref rid="btad071-B55" ref-type="bibr">Reimand and Bader, 2013</xref>; <xref rid="btad071-B56" ref-type="bibr">Ryslik <italic toggle="yes">et al.</italic>, 2013</xref>). Our comprehensive evaluation demonstrated that WMDS.net was powerful among various datasets and outperformed the other top-tier tools. Importantly, WMDS.net can effectively identify driver genes of low-frequency mutations in tumor samples and reveals the unexpectedly high tumor heterogeneity of cancer patients in the same type of cancer and thus have important implications in personalized treatment for cancer patients.</p>
  </sec>
  <sec>
    <title>2 Materials and methods</title>
    <sec>
      <title>2.1 Gene-interaction reference network</title>
      <p>We used the gene-interaction reference network constructed in Dawnrank (<xref rid="btad071-B32" ref-type="bibr">Hou and Ma, 2014</xref>), which integrated several sources, including the network used in MEMo (<xref rid="btad071-B10" ref-type="bibr">Ciriello <italic toggle="yes">et al.</italic>, 2012</xref>), the curated information from Reactome (<xref rid="btad071-B11" ref-type="bibr">Croft <italic toggle="yes">et al.</italic>, 2011</xref>), the NCI-Nature Curated PID (<xref rid="btad071-B57" ref-type="bibr">Schaefer <italic toggle="yes">et al.</italic>, 2009</xref>) and KEGG (<xref rid="btad071-B39" ref-type="bibr">Kanehisa <italic toggle="yes">et al.</italic>, 2012</xref>). The MEMo network contained inferred gene interactions, such as protein interactions, gene co-expression and protein domain interactions. There are 11 648 genes and 211 794 edges in the resulting aggregated reference network. Then, we selected the largest connected subgraph with the most nodes among all the connected subgraph of the graph as the central part of the network. Genes that have no edge connection with the central part of the network were deleted, only the central part of the network as a whole network was retained in the collected gene-interaction reference network. Because these scattered nodes without interaction with the central part are separated from most of the nodes in the network, their control impacts on the whole network are negligible.</p>
    </sec>
    <sec>
      <title>2.2 Multiple-sample differential co-expression network</title>
      <p>To quantify the edge between genes in co-expression networks, the Pearson correlation coefficients of mRNA expression profiles were used to calculate the expression correlation between genes connected in the reference network (<xref rid="btad071-F1" ref-type="fig">Fig. 1A</xref>). The Pearson correlation between expression levels of two genes (<inline-formula id="IE3"><mml:math id="IM3" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, <inline-formula id="IE4"><mml:math id="IM4" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) can be quantified:
<disp-formula id="E1"><label>(1)</label><mml:math id="M1" display="block" overflow="scroll"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">cov</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:msqrt><mml:mrow><mml:mrow><mml:mi mathvariant="normal">var</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mi mathvariant="normal">v</mml:mi><mml:mi mathvariant="normal">ar</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:msqrt></mml:mrow></mml:mrow><mml:mo>,</mml:mo></mml:math></disp-formula>where the cov represents the covariance of expression levels between two genes (<inline-formula id="IE5"><mml:math id="IM5" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, <inline-formula id="IE6"><mml:math id="IM6" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) connected in the reference network and the var represents the variance of expression levels of genes <inline-formula id="IE7"><mml:math id="IM7" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula id="IE8"><mml:math id="IM8" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>. mRNA expression for Pearson correlation analysis was quantified using Fragments Per Kilobase of transcript per Million mapped reads.</p>
      <fig position="float" id="btad071-F1">
        <label>Fig. 1.</label>
        <caption>
          <p>Overview of WMDS.net. (<bold>A</bold>) Flowchart of WMDS.net. (a) Expression matrices of samples under two conditions. (b) Co-expression network. Co-expression networks for two conditions were constructed based on the reference gene-interaction network, respectively. Each node of the co-expression network represents a gene, and the thickness of each edge represents the magnitude of Pearson correlation coefficient of two genes. (c) Differential co-expression network. The number next to the edge of the differential co-expression network represents the <italic toggle="yes">P</italic>-value of the significance test of the differences between the edges in two states. (d) Final network. Only the edges with <italic toggle="yes">P</italic>-value &lt;0.05 within the reference gene-interaction network were preserved. (e) Identification of driver nodes in the final differential expression network. WMDS was applied to find the driver genes of the final network, which are represented by black spots. (<bold>B</bold>) WMDS model. The DS is defined such that each node in the graph is either a point in DS or an adjacent to an element of DS. A MDS is the smallest DS for a given network. A set of black points in the upper panel represents an MDS in a given network. As the MDS is not unique in the whole network, we applied the WMDS model instead in which the weight integrates the degree of nodes in the network and the significance of gene co-expression difference between two states. For an intuitive illustration of WMDS, <inline-formula id="IE1"><mml:math id="IM1" display="inline" overflow="scroll"><mml:mo>γ</mml:mo></mml:math></inline-formula> was set to 1. Based on the objection function, <inline-formula id="IE2"><mml:math id="IM2" display="inline" overflow="scroll"><mml:mi>f</mml:mi><mml:mo>(</mml:mo><mml:mi>x</mml:mi><mml:mo>)</mml:mo></mml:math></inline-formula>, in the lower panel, (1, 5) is an optimal MDS for the studied network</p>
        </caption>
        <graphic xlink:href="btad071f1" position="float"/>
      </fig>
      <p>The correlation of expression levels between a pair of genes (<inline-formula id="IE9"><mml:math id="IM9" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, <inline-formula id="IE10"><mml:math id="IM10" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) in one condition was recorded as <inline-formula id="IE11"><mml:math id="IM11" display="inline" overflow="scroll"><mml:msubsup><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="double-struck">i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> and in another condition was recorded as <inline-formula id="IE12"><mml:math id="IM12" display="inline" overflow="scroll"><mml:msubsup><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="double-struck">i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula>. The significance of differential co-expression (i.e. differential edge) between two conditions was examined using <italic toggle="yes">Z</italic>-test. Briefly, the Fisher <italic toggle="yes">Z</italic>-transformation was performed to convert correlation coefficient into an approximately normally distributed measure (<xref rid="btad071-B7" ref-type="bibr">Bhuva <italic toggle="yes">et al.</italic>, 2019</xref>):
<disp-formula id="E2"><label>(2)</label><mml:math id="M2" display="block" overflow="scroll"><mml:msubsup><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac><mml:mrow><mml:mrow><mml:mi mathvariant="normal">ln</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mfenced open="|" close="|" separators="|"><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msubsup><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="double-struck">i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msubsup><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="double-struck">i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula>where <inline-formula id="IE13"><mml:math id="IM13" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> was obtained by the Fisher <italic toggle="yes">Z</italic>-transformation of <inline-formula id="IE14"><mml:math id="IM14" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>; <inline-formula id="IE15"><mml:math id="IM15" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is asymptotically the normal distribution with standard deviation of <inline-formula id="IE16"><mml:math id="IM16" display="inline" overflow="scroll"><mml:msqrt><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:mfrac></mml:msqrt></mml:math></inline-formula> (<xref rid="btad071-B19" ref-type="bibr">Fisher, 1915</xref>; <xref rid="btad071-B64" ref-type="bibr">Torres, 2020</xref>), where <inline-formula id="IE17"><mml:math id="IM17" display="inline" overflow="scroll"><mml:mi>n</mml:mi></mml:math></inline-formula> is the sample size. That is,
<disp-formula id="E3"><label>(3)</label><mml:math id="M3" display="block" overflow="scroll"><mml:msubsup><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mi mathvariant="normal"> </mml:mi><mml:mo>∼</mml:mo><mml:mi mathvariant="normal"> </mml:mi><mml:mi>N</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mo>ρ</mml:mo></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:math></disp-formula>and
<disp-formula id="E4"><label>(4)</label><mml:math id="M4" display="block" overflow="scroll"><mml:msubsup><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mi mathvariant="normal"> </mml:mi><mml:mo>∼</mml:mo><mml:mi mathvariant="normal"> </mml:mi><mml:mi>N</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mo>ρ</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:math></disp-formula>where <inline-formula id="IE18"><mml:math id="IM18" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula id="IE19"><mml:math id="IM19" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> are the sample sizes of two conditions, respectively. Under the null hypothesis that the correlation coefficients of the two population samples are equal (i.e. <inline-formula id="IE20"><mml:math id="IM20" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mo>ρ</mml:mo></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mo>ρ</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula>), we could derive the following statistic,
<disp-formula id="E5"><label>(5)</label><mml:math id="M5" display="block" overflow="scroll"><mml:mo>Δ</mml:mo><mml:msub><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mfenced open="|" close="|" separators="|"><mml:mrow><mml:msubsup><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo>-</mml:mo><mml:msubsup><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>l</mml:mi></mml:mrow><mml:mo>˙</mml:mo></mml:mover></mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:msqrt><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:mfrac></mml:msqrt></mml:mrow></mml:mfrac><mml:mi mathvariant="normal"> </mml:mi><mml:mo>∼</mml:mo><mml:mi mathvariant="normal"> </mml:mi><mml:mi>N</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mn>0,1</mml:mn></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:math></disp-formula></p>
      <p>The above statistic <inline-formula id="IE21"><mml:math id="IM21" display="inline" overflow="scroll"><mml:mo>Δ</mml:mo><mml:msub><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is asymptotically the normal distribution with a mean of zero and a standard deviation of<inline-formula id="IE22"><mml:math id="IM22" display="inline" overflow="scroll"><mml:mi mathvariant="normal"> </mml:mi></mml:math></inline-formula>1.</p>
      <p>To assess the influence of sample sizes on the construction of differential co-expression networks, we simulated the distribution of <inline-formula id="IE23"><mml:math id="IM23" display="inline" overflow="scroll"><mml:mo>Δ</mml:mo><mml:mi>Z</mml:mi></mml:math></inline-formula> under the null hypothesis by randomly generating two pairs of sequences with sample size of 5, 8, 10, 15 and 20, 100 for 2 000 000 times. Kolmogorov–Smirnov test was used to examine whether the simulated distribution is identical to standard normal distribution. As shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1</xref>, the distribution of <inline-formula id="IE24"><mml:math id="IM24" display="inline" overflow="scroll"><mml:mo>Δ</mml:mo><mml:mi>Z</mml:mi></mml:math></inline-formula> is a good approximation of standard normal distribution when the sample size is &gt;15. In other words, <italic toggle="yes">P</italic>-values estimated for differential edges between two conditions are valid for sample size as small as 15.</p>
    </sec>
    <sec>
      <title>2.3 Personalized differential co-expression network</title>
      <p>Considering the individual heterogeneity of a certain type of cancer, we also constructed personalized differential co-expression networks using the sample specific network (SSN) (<xref rid="btad071-B46" ref-type="bibr">Liu <italic toggle="yes">et al.</italic>, 2016</xref>). For a group of normal samples (<inline-formula id="IE25"><mml:math id="IM25" display="inline" overflow="scroll"><mml:mi>n</mml:mi></mml:math></inline-formula> samples), the correlation <inline-formula id="IE26"><mml:math id="IM26" display="inline" overflow="scroll"><mml:msubsup><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="double-struck">i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> of a pair of genes was calculated according to the expression data of these samples to construct the co-expression reference network. In general, the normal sample reference network contains the common properties of these normal samples. Next, an individual tumor sample from a cancer patient was added to the reference samples, and the correlation <inline-formula id="IE27"><mml:math id="IM27" display="inline" overflow="scroll"><mml:msubsup><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="double-struck">i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> of a pair of genes was re-calculated to construct a co-expression perturbed network due to this additional tumor sample. The difference between the corresponding edges of co-expression reference network and the co-expression perturbed network, i.e. <inline-formula id="IE28"><mml:math id="IM28" display="inline" overflow="scroll"><mml:mo>Δ</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msubsup><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="double-struck">i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo>-</mml:mo><mml:msubsup><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="double-struck">i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula>, was calculated. Then, <inline-formula id="IE29"><mml:math id="IM29" display="inline" overflow="scroll"><mml:mo>Δ</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> was transformed into <italic toggle="yes">Z</italic>-score, and <italic toggle="yes">P</italic>-value for <inline-formula id="IE30"><mml:math id="IM30" display="inline" overflow="scroll"><mml:mo>Δ</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> was obtained from <italic toggle="yes">Z</italic>-test. If <italic toggle="yes">P</italic>-value &lt;0.05, the edge <inline-formula id="IE31"><mml:math id="IM31" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is retained for that patient (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S2</xref>). Finally, we predicted personal driver genes for each cancer patient on their personalized differential co-expression network using WMDS.</p>
    </sec>
    <sec>
      <title>2.4 WMDS model</title>
      <p>The definition of MDS is as follow. Given a gene network, which can be represented by a graph <inline-formula id="IE32"><mml:math id="IM32" display="inline" overflow="scroll"><mml:mi>G</mml:mi><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:mi>V</mml:mi><mml:mo>,</mml:mo><mml:mi>E</mml:mi><mml:mo>)</mml:mo></mml:math></inline-formula>, where <inline-formula id="IE33"><mml:math id="IM33" display="inline" overflow="scroll"><mml:mi>V</mml:mi></mml:math></inline-formula> is the set of gene nodes and <inline-formula id="IE34"><mml:math id="IM34" display="inline" overflow="scroll"><mml:mi>E</mml:mi></mml:math></inline-formula> is the set of edges between genes, if each gene <inline-formula id="IE35"><mml:math id="IM35" display="inline" overflow="scroll"><mml:mi>v</mml:mi><mml:mo>∈</mml:mo><mml:mi>V</mml:mi></mml:math></inline-formula> is an element of the DS set or is adjacent to an element in the DS set, DS is a dominating set (<xref rid="btad071-B52" ref-type="bibr">Nacher and Akutsu, 2012</xref>). The MDS is the minimum DS of the gene network (<xref rid="btad071-F1" ref-type="fig">Fig. 1B</xref>). Since the dominating problem is a classical non-deterministic polynomial-hard problem in computational complexity theory (<xref rid="btad071-B31" ref-type="bibr">Haynes <italic toggle="yes">et al.</italic>, 1998</xref>), there is no polynomial time algorithm to find the MDS of arbitrary graphs. Therefore, we simplified the dominating problem to a binary integer programming problem. Binary integer programming is a mathematic algorithm for finding a binary vector x, which minimizes the linear function <inline-formula id="IE36"><mml:math id="IM36" display="inline" overflow="scroll"><mml:mi>f</mml:mi><mml:mo>(</mml:mo><mml:mi>x</mml:mi><mml:mo>)</mml:mo></mml:math></inline-formula> subject to linear constraints. Each node <inline-formula id="IE37"><mml:math id="IM37" display="inline" overflow="scroll"><mml:mi>i</mml:mi></mml:math></inline-formula> is assigned to a binary integer variable <inline-formula id="IE38"><mml:math id="IM38" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> taking 0 or 1. If node <inline-formula id="IE39"><mml:math id="IM39" display="inline" overflow="scroll"><mml:mi>i</mml:mi></mml:math></inline-formula> belongs to the MDS, then <inline-formula id="IE40"><mml:math id="IM40" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> takes 1, otherwise takes 0. To calculate MDS, we considered the minimization of the following linear functions:
<disp-formula id="E6"><label>(6)</label><mml:math id="M6" display="block" overflow="scroll"><mml:mi>f</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mo>⋯</mml:mo><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:munderover><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></disp-formula>subject to the constraints:
<disp-formula id="E7"><mml:math id="M7" display="block" overflow="scroll"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:munder><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>∈</mml:mo><mml:mo>∂</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:munder><mml:mrow><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>≥</mml:mo><mml:mn>1</mml:mn></mml:math></disp-formula>where <inline-formula id="IE41"><mml:math id="IM41" display="inline" overflow="scroll"><mml:mo>∂</mml:mo><mml:mi>i</mml:mi></mml:math></inline-formula> is the adjacent node of <inline-formula id="IE42"><mml:math id="IM42" display="inline" overflow="scroll"><mml:mi>i</mml:mi></mml:math></inline-formula> and <inline-formula id="IE43"><mml:math id="IM43" display="inline" overflow="scroll"><mml:mi>n</mml:mi></mml:math></inline-formula> is the total number of nodes in the network.</p>
      <p>As shown in <xref rid="btad071-F1" ref-type="fig">Figure 1B</xref>, there may be more than one optimal solution for the binary integer programming problem in a given network. It is challenging to determine which one is the real set of critical nodes that controls the whole biological network. To solve this problem, we applied a method similar to that of <xref rid="btad071-B2" ref-type="bibr">Bakhteh <italic toggle="yes">et al.</italic> (2020)</xref> to compute a heuristic approximation of the weighted minimum dominating set (WMDS) (<xref rid="btad071-B22" ref-type="bibr">Garey and Johnson, 1990</xref>), where biologically meaningful information was incorporated into the weights. This weighted approach allows us to select an MDS configuration that best represents a set of key nodes that likely govern the entire differential co-expression network. Firstly, the driver nodes often show high connectivity in the gene network (<xref rid="btad071-B12" ref-type="bibr">D'Antonio and Ciccarelli, 2013</xref>; <xref rid="btad071-B40" ref-type="bibr">Khurana <italic toggle="yes">et al.</italic>, 2013</xref>). For gene-interaction networks, it is known that cancer driver genes tend to have high degree (<xref rid="btad071-B58" ref-type="bibr">Schaefer <italic toggle="yes">et al.</italic>, 2015</xref>). Thus, we set the weight of the nodes as degree of the nodes of differential co-expression network. Secondly, the significant difference in the co-expression correlation of genes between two conditions indicates that these genes may play an important role in steering the network from one state to another state. Living cells often undergo dramatic rewiring of transcriptional co-expression networks during different developmental stages, transitions between different cellular states, or progression from normal to disease states (<xref rid="btad071-B20" ref-type="bibr">Flintoft, 2004</xref>). Molecular disease phenotypes typically constitute abnormalities in the co-regulation of genes (<xref rid="btad071-B23" ref-type="bibr">Golub <italic toggle="yes">et al.</italic>, 1999</xref>). Studies also showed that disruption of co-expression among genes is prevalent during tumorigenesis (<xref rid="btad071-B17" ref-type="bibr">Deng <italic toggle="yes">et al.</italic>, 2015</xref>; <xref rid="btad071-B45" ref-type="bibr">Lin <italic toggle="yes">et al.</italic>, 2015</xref>). Therefore, we further considered the edge weight that represents the confidences of the interaction between genes in the differential co-expression network. We hypothesized that genes with high degree of connectivity and significant correlation difference are more likely to become key players in the network state transition. Therefore, we defined the weight <inline-formula id="IE44"><mml:math id="IM44" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mo>（</mml:mo><mml:mrow><mml:munder><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>∈</mml:mo><mml:mo>∂</mml:mo><mml:mi mathvariant="double-struck">i</mml:mi></mml:mrow></mml:munder><mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">log</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:mrow></mml:mrow><mml:mo>）</mml:mo></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mo>γ</mml:mo></mml:mrow></mml:msup></mml:math></inline-formula> of each gene <italic toggle="yes">i</italic>, where ∂<inline-formula id="IE45"><mml:math id="IM45" display="inline" overflow="scroll"><mml:mi mathvariant="double-struck">i</mml:mi></mml:math></inline-formula> is the set of adjacent genes of gene <inline-formula id="IE46"><mml:math id="IM46" display="inline" overflow="scroll"><mml:mi>i</mml:mi></mml:math></inline-formula>; <inline-formula id="IE47"><mml:math id="IM47" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the <italic toggle="yes">P</italic>-value of significant difference in the co-expression correlation of gene <inline-formula id="IE48"><mml:math id="IM48" display="inline" overflow="scroll"><mml:mi>i</mml:mi></mml:math></inline-formula> and adjacent gene<inline-formula id="IE49"><mml:math id="IM49" display="inline" overflow="scroll"><mml:mi mathvariant="normal"> </mml:mi><mml:mi>j</mml:mi></mml:math></inline-formula> between the two states; γ (&gt; 0) is a hyperparameter controlling the weights (<xref rid="btad071-B69" ref-type="bibr">Zhang <italic toggle="yes">et al.</italic>, 2015</xref>) to ensure that the number of nodes in weighed dominating set (WDS) is the same as in all MDS configurations, thereby minimizing the number of nodes in WDS. In other words, we ensure that the WDS is a configuration choice among all MDS configurations, i.e. it becomes WMDS. If γ =  0, then <inline-formula id="IE50"><mml:math id="IM50" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:math></inline-formula>, i.e. there is no weight for each node. We set <inline-formula id="IE51"><mml:math id="IM51" display="inline" overflow="scroll"><mml:mo>γ</mml:mo><mml:mo>=</mml:mo><mml:mn>0.01</mml:mn></mml:math></inline-formula> in our WMDS model.</p>
      <p>Then, the binary integer programming problem is transformed into the minimization of the following linear functions:
<disp-formula id="E8"><label>(7)</label><mml:math id="M8" display="block" overflow="scroll"><mml:mi>f</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mo>⋯</mml:mo><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:munderover><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></disp-formula>subject to the constraints:
<disp-formula id="E9"><mml:math id="M9" display="block" overflow="scroll"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:munder><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>∈</mml:mo><mml:mo>∂</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:munder><mml:mrow><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>≥</mml:mo><mml:mn>1</mml:mn></mml:math></disp-formula>where <inline-formula id="IE52"><mml:math id="IM52" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the weight of gene <inline-formula id="IE53"><mml:math id="IM53" display="inline" overflow="scroll"><mml:mi>i</mml:mi></mml:math></inline-formula> and <inline-formula id="IE54"><mml:math id="IM54" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> takes 1 or 0. Among all the MDS configurations, we tended to select the MDS whose members have the highest degree and most significant difference of co-expression correlation in a given network. For example, in <xref rid="btad071-F1" ref-type="fig">Figure 1B</xref>, several optional gene sets, such as <inline-formula id="IE55"><mml:math id="IM55" display="inline" overflow="scroll"><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mn>1,5</mml:mn></mml:mrow></mml:mfenced><mml:mo>,</mml:mo><mml:mi mathvariant="normal"> </mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mn>1,6</mml:mn></mml:mrow></mml:mfenced><mml:mo>,</mml:mo><mml:mi mathvariant="normal"> </mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mn>2,5</mml:mn></mml:mrow></mml:mfenced><mml:mi mathvariant="normal"> </mml:mi><mml:mi mathvariant="normal">and</mml:mi><mml:mi mathvariant="normal"> </mml:mi><mml:mo>(</mml:mo><mml:mn>3,5</mml:mn><mml:mo>)</mml:mo></mml:math></inline-formula>, can be selected as the driver node set of the network by applying MDS model. If the WMDS model is applied, the weight of <inline-formula id="IE56"><mml:math id="IM56" display="inline" overflow="scroll"><mml:mo>(</mml:mo><mml:mn>1,5</mml:mn><mml:mo>)</mml:mo></mml:math></inline-formula> in these optional choices is the minimum. Taken together, the WMDS model tends to predict genes with high degree of connectivity and significant difference of co-expression correlation in a given network as driver nodes. The source codes to implement WMDS.net are available at <ext-link xlink:href="https://github.com/chaofen123/DriverWMDS" ext-link-type="uri">https://github.com/chaofen123/WMDS.net</ext-link>.</p>
    </sec>
    <sec>
      <title>2.5 <italic toggle="yes">F</italic>-measure evaluation criteria</title>
      <p><italic toggle="yes">F</italic>-measure was used to evaluate the efficiency of WMDS.net and other driver prediction tools, which is the weighted harmonic mean of precision and recall with non-negative weight <inline-formula id="IE57"><mml:math id="IM57" display="inline" overflow="scroll"><mml:mo>β</mml:mo></mml:math></inline-formula>. <italic toggle="yes">F</italic>-measure was calculated as follows:
<disp-formula id="E10"><mml:math id="M10" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:mi mathvariant="normal">Precision</mml:mi><mml:mi mathvariant="normal"> </mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">true</mml:mi><mml:mi mathvariant="normal"> </mml:mi><mml:mi mathvariant="normal">positive</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">true</mml:mi><mml:mi mathvariant="normal"> </mml:mi><mml:mi mathvariant="normal">positive</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">false</mml:mi><mml:mi mathvariant="normal"> </mml:mi><mml:mi mathvariant="normal">positive</mml:mi></mml:mrow></mml:mfrac></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mtable><mml:mtr><mml:mtd><mml:mi mathvariant="normal">Recall</mml:mi><mml:mi mathvariant="normal"> </mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">true</mml:mi><mml:mi mathvariant="normal"> </mml:mi><mml:mi mathvariant="normal">positive</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">true</mml:mi><mml:mi mathvariant="normal"> </mml:mi><mml:mi mathvariant="normal">positive</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">false</mml:mi><mml:mi mathvariant="normal"> </mml:mi><mml:mi mathvariant="normal">negative</mml:mi></mml:mrow></mml:mfrac></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mo>β</mml:mo></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mo>β</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfenced><mml:mi mathvariant="normal">Precision</mml:mi><mml:mi mathvariant="normal"> </mml:mi><mml:mo>×</mml:mo><mml:mi mathvariant="normal"> </mml:mi><mml:mi mathvariant="normal">Recall</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mo>β</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mi mathvariant="normal">Precision</mml:mi><mml:mi mathvariant="normal"> </mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal"> </mml:mi><mml:mi mathvariant="normal">Recall</mml:mi></mml:mrow></mml:mfrac></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>where <inline-formula id="IE58"><mml:math id="IM58" display="inline" overflow="scroll"><mml:msup><mml:mrow><mml:mo>β</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math></inline-formula> is generally taken as the value of 0.3, which is based on the experience of many target detection works (<xref rid="btad071-B1" ref-type="bibr">Achanta <italic toggle="yes">et al.</italic>, 2009</xref>; <xref rid="btad071-B8" ref-type="bibr">Cheng <italic toggle="yes">et al.</italic>, 2015</xref>; <xref rid="btad071-B54" ref-type="bibr">Perazzi <italic toggle="yes">et al.</italic>, 2012</xref>). In other words, the weight of precision is promoted since the precision is considered more important than the recall in real experiments. In the evaluation of cancer driver gene prediction, we found that <inline-formula id="IE59"><mml:math id="IM59" display="inline" overflow="scroll"><mml:msup><mml:mrow><mml:mo>β</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math></inline-formula> taken with the value of 0.2 is objective and fair, according to the total number of genes on the genome and the number of driver genes in the standard gene list. If we take <inline-formula id="IE60"><mml:math id="IM60" display="inline" overflow="scroll"><mml:msup><mml:mrow><mml:mo>β</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:math></inline-formula> (denoted as <italic toggle="yes">F</italic>1-measure), which was used by some previous tools (<xref rid="btad071-B28" ref-type="bibr">Guo <italic toggle="yes">et al.</italic>, 2019</xref>), i.e. the importance of precision and recall is the same. However, even if nothing is done, the <italic toggle="yes">F</italic>1-measure is not low with all genes predicted as driver genes in which the precision is very low, but the recall will be equal to 1. For example, there are 616 genes in the cancer gene census (CGC) gene list, and the prediction of all 25 000 genes on the genome as driver genes is more efficient than some existing tools (e.g. DriverML and DawnRank) with excellent precision according to the <italic toggle="yes">F</italic>1-measure. Therefore, we analyzed the two worst cases: (i) all 25 000 genes are predicted as driver genes when the recall is 1, and (ii) only 2∼3 genes are predicted as driver genes when the precision is 1. In order that the evaluation criteria will not be biased toward tools with more or less predictions, we chose an appropriate <inline-formula id="IE61"><mml:math id="IM61" display="inline" overflow="scroll"><mml:msup><mml:mrow><mml:mo>β</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math></inline-formula> (i.e. a value of 0.2) so that the <italic toggle="yes">F</italic>-measures of the two worst cases are equal. In addition, the <italic toggle="yes">F</italic>1-measure (i.e. <inline-formula id="IE62"><mml:math id="IM62" display="inline" overflow="scroll"><mml:msup><mml:mrow><mml:mo>β</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:math></inline-formula>) was provided in the <xref rid="sup1" ref-type="supplementary-material">Supplementary Material</xref>.</p>
    </sec>
    <sec>
      <title>2.6 Data collection</title>
      <p>The mRNA expression profiles of 14 types of common cancer from TCGA were used for identifying driver genes, each of which contained more than 15 normal samples (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>). These cancer types included bladder urothelial carcinoma (BLCA), breast invasive carcinoma (BRCA), colon adenocarcinoma (COAD), head and neck squamous cell carcinoma (HNSC), kidney chromophobe (KICH), kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma (KIRP), liver hepatocellular carcinoma (LIHC), lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), prostate adenocarcinoma (PRAD), stomach adenocarcinoma (STAD), papillary thyroid carcinoma (THCA)) and uterine corpus endometrial carcinoma (UCEC). Gene expression and single nucleotide variation (SNV) data were downloaded from the Genomic Data Commons (<ext-link xlink:href="https://portal.gdc.cancer.gov" ext-link-type="uri">https://portal.gdc.cancer.gov</ext-link>). The gene list of CGC was downloaded from the COSMIC website (<ext-link xlink:href="https://cancer.sanger.ac.uk/cosmic" ext-link-type="uri">https://cancer.sanger.ac.uk/cosmic</ext-link>). The gene list of network of cancer genes (NCG) was downloaded from the web resource (<ext-link xlink:href="http://ncg.kcl.ac.uk/download.php" ext-link-type="uri">http://ncg.kcl.ac.uk/download.php</ext-link>). The gene lists of Pan-cancer drivers, Mut-drivers and Hiconf drivers were extracted from previous studies (<xref rid="btad071-B41" ref-type="bibr">Kumar <italic toggle="yes">et al.</italic>, 2015</xref>; Tamborero <italic toggle="yes">et al.</italic>, 2013a; <xref rid="btad071-B67" ref-type="bibr">Vogelstein <italic toggle="yes">et al.</italic>, 2013</xref>) and merged into one list (denoted as PMH).</p>
    </sec>
    <sec>
      <title>2.7 Other tools for predicting cancer driver genes</title>
      <p>In the application of detecting cancer driver genes, we compared our methods with other 11 top-tier tools in the TCGA datasets. These tools detect driver genes either by somatic mutation frequency, or gene expression, or gene or protein interaction networks. This allows us to conduct an unbiased and comprehensive evaluation of our newly proposed WMDS.net. They included DrGap (<xref rid="btad071-B34" ref-type="bibr">Hua <italic toggle="yes">et al.</italic>, 2013</xref>), OncoDriveFM (<xref rid="btad071-B24" ref-type="bibr">Gonzalez-Perez and Lopez-Bigas, 2012</xref>), MutSigCV (<xref rid="btad071-B44" ref-type="bibr">Lawrence <italic toggle="yes">et al.</italic>, 2013</xref>), DriverML (<xref rid="btad071-B30" ref-type="bibr">Han <italic toggle="yes">et al.</italic>, 2019</xref>), PNC (<xref rid="btad071-B28" ref-type="bibr">Guo <italic toggle="yes">et al.</italic>, 2019</xref>), DawnRank (<xref rid="btad071-B32" ref-type="bibr">Hou and Ma, 2014</xref>), SCS (<xref rid="btad071-B27" ref-type="bibr">Guo <italic toggle="yes">et al.</italic>, 2018</xref>), DriverNet (<xref rid="btad071-B5" ref-type="bibr">Bashashati <italic toggle="yes">et al.</italic>, 2012</xref>), ActiveDriver (<xref rid="btad071-B55" ref-type="bibr">Reimand and Bader, 2013</xref>), iPAC (<xref rid="btad071-B56" ref-type="bibr">Ryslik <italic toggle="yes">et al.</italic>, 2013</xref>) and MSEA (<xref rid="btad071-B38" ref-type="bibr">Jia <italic toggle="yes">et al.</italic>, 2014</xref>). Predictions of driver genes in the other tools were obtained from the DriverDBv2 database (<xref rid="btad071-B9" ref-type="bibr">Chung <italic toggle="yes">et al.</italic>, 2016</xref>).</p>
    </sec>
  </sec>
  <sec>
    <title>3 Results</title>
    <sec>
      <title>3.1 Overview of WMDS.net</title>
      <p>WMDS.net is an innovative network control approach to identify key players in gene co-expression networks (<ext-link xlink:href="https://github.com/chaofen123/DriverWMDS" ext-link-type="uri">https://github.com/chaofen123/WMDS.net</ext-link>). It mainly consists of two steps (<xref rid="btad071-F1" ref-type="fig">Fig. 1A</xref>). First, we obtained a priori gene-interaction network that contains highly credible interactions between gene pairs from various data resources (<xref rid="btad071-B10" ref-type="bibr">Ciriello <italic toggle="yes">et al.</italic>, 2012</xref>; <xref rid="btad071-B11" ref-type="bibr">Croft <italic toggle="yes">et al.</italic>, 2011</xref>; <xref rid="btad071-B32" ref-type="bibr">Hou and Ma, 2014</xref>; <xref rid="btad071-B39" ref-type="bibr">Kanehisa <italic toggle="yes">et al.</italic>, 2012</xref>; <xref rid="btad071-B57" ref-type="bibr">Schaefer <italic toggle="yes">et al.</italic>, 2009</xref>). From this reference network, we constructed the co-expression networks of two different conditions (e.g. normal state and tumor state) using high-throughput expression profiles, and further integrated the two networks into the final differential co-expression network. Second, we employed the WMDS network model (<xref rid="btad071-F1" ref-type="fig">Fig. 1B</xref>) to predict driver nodes that can steer the transcriptomic biological network from one state to another. The transcriptional co-expression network can be represented as an undirected graph, in which the graph nodes correspond to genes and edges between genes correspond to significant interactive relations. Then, we applied WMDS to find the driver nodes in the whole network. In the WMDS model, the weight integrates the degree of nodes in the network and the significance of gene co-expression difference between two conditions. In the context of cancer, we could also construct individualized differential co-expression networks using the SSN (<xref rid="btad071-B46" ref-type="bibr">Liu <italic toggle="yes">et al.</italic>, 2016</xref>) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S2</xref>) to find the cancer patient-specific driver gene set.</p>
    </sec>
    <sec>
      <title>3.2 Construction of differential co-expression networks in TCGA datasets</title>
      <p>Driver nodes of transcriptional networks in tumor cells are potential cancer driver genes that play key roles in reprograming tumor cellular phenotypes from a normal state to hyper-proliferative state. To illustrate the utility of WMDS.net, we applied it to analyze RNA-seq data to predict cancer driver genes in TCGA. We thus constructed differential co-expression networks in 14 major types of cancer from TCGA (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>) each of which had at least 15 normal samples (<xref rid="btad071-F2" ref-type="fig">Fig. 2A</xref>). Most biologically relevant networks are scale free, which consist of many lowly connected genes and a small number of highly connected ‘hub’ genes (<xref rid="btad071-B6" ref-type="bibr">Basso <italic toggle="yes">et al.</italic>, 2005</xref>; <xref rid="btad071-B65" ref-type="bibr">van Noort <italic toggle="yes">et al.</italic>, 2004</xref>). This kind of biological network often have a power-law distribution (<xref rid="btad071-B3" ref-type="bibr">Barabasi and Albert, 1999</xref>), i.e. the frequency distribution of degree follows <inline-formula id="IE63"><mml:math id="IM63" display="inline" overflow="scroll"><mml:mi>p</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:mfenced><mml:mo>∼</mml:mo><mml:msup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mo>γ</mml:mo></mml:mrow></mml:msup></mml:math></inline-formula>. To visually inspect whether an approximate scale-free topology is satisfied, we plotted <inline-formula id="IE64"><mml:math id="IM64" display="inline" overflow="scroll"><mml:mi mathvariant="normal">log</mml:mi><mml:mn>2</mml:mn><mml:mo>(</mml:mo><mml:mi mathvariant="normal">numbers</mml:mi><mml:mi mathvariant="normal"> </mml:mi><mml:mi mathvariant="normal">of</mml:mi><mml:mi mathvariant="normal"> </mml:mi><mml:mi mathvariant="normal">degree</mml:mi><mml:mo>)</mml:mo></mml:math></inline-formula> versus <inline-formula id="IE65"><mml:math id="IM65" display="inline" overflow="scroll"><mml:mi mathvariant="normal">log</mml:mi><mml:mn>2</mml:mn><mml:mi mathvariant="normal"> </mml:mi><mml:mo>(</mml:mo><mml:mi mathvariant="normal">degree</mml:mi><mml:mo>)</mml:mo></mml:math></inline-formula> for the constructed differential co-expression networks of all 14 cancer types in TCGA (<xref rid="btad071-F2" ref-type="fig">Fig. 2B</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S3</xref>). The straight line is indicative of scale-free topology. The fitting index <italic toggle="yes">R</italic>-square (<inline-formula id="IE66"><mml:math id="IM66" display="inline" overflow="scroll"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math></inline-formula>) of linear regression model can be used to quantify how well a network satisfies a scale-free topology, and <inline-formula id="IE67"><mml:math id="IM67" display="inline" overflow="scroll"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>&gt;</mml:mo><mml:mn>0.80</mml:mn></mml:math></inline-formula> is a better approximation (<xref rid="btad071-B68" ref-type="bibr">Zhang and Horvath, 2005</xref>). As shown in <xref rid="btad071-F2" ref-type="fig">Figure 2C</xref>, <inline-formula id="IE68"><mml:math id="IM68" display="inline" overflow="scroll"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math></inline-formula> on most TCGA datasets are &gt;0.9, indicating that our differential co-expression networks satisfy the approximate scale-free topology well. Therefore, these differential co-expression networks constructed from TCGA datasets are of biological significance and are suitable for finding driver nodes that control the whole transcriptome network switching between the normal and tumor states.</p>
      <fig position="float" id="btad071-F2">
        <label>Fig. 2.</label>
        <caption>
          <p>Differential gene co-expression networks. (<bold>A</bold>) Final transcriptome network constructed by WMDS.net. There were 8745 genes and 174 923 edges in the resulting aggregated network in BRCA. (<bold>B</bold>) Overall degree distribution of network nodes from 14 TCGA datasets. In each cancer type, <inline-formula id="IE69"><mml:math id="IM69" display="inline" overflow="scroll"><mml:mi mathvariant="normal">log</mml:mi><mml:mn>2</mml:mn><mml:mo>(</mml:mo><mml:mi mathvariant="normal">numbers</mml:mi><mml:mi mathvariant="normal"> </mml:mi><mml:mi mathvariant="normal">of</mml:mi><mml:mi mathvariant="normal"> </mml:mi><mml:mi mathvariant="normal">degree</mml:mi><mml:mo>)</mml:mo></mml:math></inline-formula> versus <inline-formula id="IE70"><mml:math id="IM70" display="inline" overflow="scroll"><mml:mi mathvariant="normal">log</mml:mi><mml:mn>2</mml:mn><mml:mi mathvariant="normal"> </mml:mi><mml:mo>(</mml:mo><mml:mi mathvariant="normal">degree</mml:mi><mml:mo>)</mml:mo></mml:math></inline-formula> for the constructed differential co-expression networks was plotted. (<bold>C</bold>) <italic toggle="yes">R</italic><sup>2</sup> of the fitting linear regression model with <inline-formula id="IE71"><mml:math id="IM71" display="inline" overflow="scroll"><mml:mi mathvariant="normal">log</mml:mi><mml:mn>2</mml:mn><mml:mo>(</mml:mo><mml:mi mathvariant="normal">numbers</mml:mi><mml:mi mathvariant="normal"> </mml:mi><mml:mi mathvariant="normal">of</mml:mi><mml:mi mathvariant="normal"> </mml:mi><mml:mi mathvariant="normal">degree</mml:mi><mml:mo>)</mml:mo></mml:math></inline-formula> as a response variable and <inline-formula id="IE72"><mml:math id="IM72" display="inline" overflow="scroll"><mml:mi mathvariant="normal">log</mml:mi><mml:mn>2</mml:mn><mml:mi mathvariant="normal"> </mml:mi><mml:mo>(</mml:mo><mml:mi mathvariant="normal">degree</mml:mi><mml:mo>)</mml:mo></mml:math></inline-formula> as an independent variable in each cancer type. <italic toggle="yes">R</italic><sup>2</sup> quantifies how well a network satisfies a scale-free topology</p>
        </caption>
        <graphic xlink:href="btad071f2" position="float"/>
      </fig>
    </sec>
    <sec>
      <title>3.3 Performance evaluation of WMDS.net in predicting cancer driver genes</title>
      <p>To evaluate the efficiency of our method in predicting cancer driver genes, we collected 616 and 711 cancer-associated genes from the CGC (<ext-link xlink:href="https://cancer.sanger.ac.uk/cosmic" ext-link-type="uri">https://cancer.sanger.ac.uk/cosmic</ext-link>) and NCG (<ext-link xlink:href="http://ncg.kcl.ac.uk/download.php" ext-link-type="uri">http://ncg.kcl.ac.uk/download.php</ext-link>) databases, respectively. The true cancer driver genes are not known, however, well curated cancer gene databases, such as CGC and NCG, provide approximate benchmarks for true cancer drivers. The CGC database manually collected a set of genes whose mutations have a causal relationship with cancer. The NCG database collected a comprehensive catalogue of known and candidate cancer genes from various tumor genome sequencing projects. In view of the potential biased nature of CGC and NCG databases and the fact that many cancer genes have not yet been discovered, the researchers identified several additional sets of putative cancer genes from other data sources. Tamborero <italic toggle="yes">et al.</italic> identified mutational cancer driver genes across 12 cancer types (denoted as Pan-cancer drivers) from TCGA (<xref rid="btad071-B62" ref-type="bibr">Tamborero <italic toggle="yes">et al.</italic>, 2013a</xref>). Genes in the Pan-cancer list were predicted as cancer drivers by at least three of the four following tools: MuSiC (<xref rid="btad071-B15" ref-type="bibr">Dees <italic toggle="yes">et al.</italic>, 2012</xref>), OncodriveFM (<xref rid="btad071-B24" ref-type="bibr">Gonzalez-Perez and Lopez-Bigas, 2012</xref>), OncodriveCLUST (<xref rid="btad071-B63" ref-type="bibr">Tamborero <italic toggle="yes">et al.</italic>, 2013b</xref>) and ActiveDriver (<xref rid="btad071-B55" ref-type="bibr">Reimand and Bader, 2013</xref>). Using the ‘20/20’ rule, Vogelstein <italic toggle="yes">et al.</italic> reported a list of Mut-driver genes that were determined by their mutation patterns rather than mutation frequencies (<xref rid="btad071-B67" ref-type="bibr">Vogelstein <italic toggle="yes">et al.</italic>, 2013</xref>). In addition, Kumar <italic toggle="yes">et al.</italic> identified a set of high confident (Hiconf) cancer genes through comprehensive literature search (<xref rid="btad071-B41" ref-type="bibr">Kumar <italic toggle="yes">et al.</italic>, 2015</xref>). We integrated the last three sets of cancer-associated genes (i.e. Pan-cancer, Mut-driver and Hiconf) into one gene set (denoted as PMH), which includes 501 genes and is different mostly from the CGC gene list.</p>
      <p>In the following, we compared the performance of our method with other 11 top-tier tools (<xref rid="btad071-B5" ref-type="bibr">Bashashati <italic toggle="yes">et al.</italic>, 2012</xref>; <xref rid="btad071-B24" ref-type="bibr">Gonzalez-Perez and Lopez-Bigas, 2012</xref>; <xref rid="btad071-B27" ref-type="bibr">Guo <italic toggle="yes">et al.</italic>, 2018</xref>, <xref rid="btad071-B28" ref-type="bibr">2019</xref>; <xref rid="btad071-B30" ref-type="bibr">Han <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btad071-B32" ref-type="bibr">Hou and Ma, 2014</xref>; <xref rid="btad071-B34" ref-type="bibr">Hua <italic toggle="yes">et al.</italic>, 2013</xref>; <xref rid="btad071-B38" ref-type="bibr">Jia <italic toggle="yes">et al.</italic>, 2014</xref>; <xref rid="btad071-B44" ref-type="bibr">Lawrence <italic toggle="yes">et al.</italic>, 2013</xref>; <xref rid="btad071-B55" ref-type="bibr">Reimand and Bader, 2013</xref>; <xref rid="btad071-B56" ref-type="bibr">Ryslik <italic toggle="yes">et al.</italic>, 2013</xref>) in various TCGA datasets based on the above three benchmarks for cancer driver genes (i.e. CGC, NCG and PMH). These selected tools not only perform well, but also are widely used in the field. Furthermore, these tools are based on different principles to detect driver genes, such as through somatic mutation frequency, gene expression or gene or protein interaction network. This will help us to make an unbiased and comprehensive assessment of our newly proposed WMDS.net. F0.2-measure evaluation criteria were used to assess the performance of these driver gene prediction tools in 14 TCGA datasets. F0.2-measure is a comprehensive indicator that simultaneously evaluates accuracy and recall from a balanced perspective.</p>
      <p>In each dataset, our method predicted two lists of cancer driver genes using the WMDS network control algorithm. One was based on the multi-sample differential co-expression network (denoted as WMDS.net). WMDS.net can capture the transition between the normal state and the tumor state of a specific type of cancer at the global level. We also wanted to evaluate the performance of our method at the individual patient level. Therefore, the other one was based on the single patient-specific personalized differential co-expression network (denoted as WMDS.netP). In the WMDS.netP method, each cancer patient yielded a list of personalized driver genes. For fair comparison with other driver prediction tools, if the frequencies of the patient’s personalized driver genes in the specific cancer type were ≥0.5, they were merged into a final list. The resulting final list represents driver genes of this cancer type that were predicted at the global level.</p>
      <p>We first compared WMDS.net with an unweighted MDS method, where one of MDS configurations was randomly selected to represent critical nodes of the differential co-expression network. As shown in <xref rid="btad071-F3" ref-type="fig">Figure 3A</xref>, compared with the unweighted MDS, incorporating biologically meaningful weights significantly improved the performance of our method in predicting cancer driver genes. Next, we compared WMDS.net with a naive ‘degree only’ baseline method that ranks genes by their vertex score (<xref rid="btad071-F3" ref-type="fig">Fig. 3A</xref>). For a fair comparison, we selected the same number of driver genes predicted by the ‘degree only’ baseline method as WMDS.net. This comparison showed that WMDS.net performed much better than the naive ‘degree only’ baseline largely due to the use of MDS in the differential co-expression network.</p>
      <fig position="float" id="btad071-F3">
        <label>Fig. 3.</label>
        <caption>
          <p>F0.2-measure of predicted driver genes in 14 TCGA datasets. (<bold>A</bold>) Comparisons of our method with an unweighted method and a naive ‘degree only’ baseline. (<bold>B</bold>) CGC benchmark. (<bold>C</bold>) NCG benchmark. (<bold>D</bold>) PMH benchmark. Tools were ordered by their median F0.2-measure of predicted drivers in each benchmark among 14 cancer types</p>
        </caption>
        <graphic xlink:href="btad071f3" position="float"/>
      </fig>
      <p>Then, we compared the performance of our method with 11 other tools in three benchmarks. In the CGC benchmark, WMDS.netP and WMDS.net achieved the two highest F0.2-measure values, ∼30% higher than PNC that ranked third (<xref rid="btad071-F3" ref-type="fig">Fig. 3B</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S4</xref>). Notably, WMDS.net not only produced high F0.2-measure values, but also produced less variation in F0.2-measure values. In the NCC benchmark, WMDS.netP and WMDS.net also performed best among these driver gene prediction tools (<xref rid="btad071-F3" ref-type="fig">Fig. 3C</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S5</xref>). In the PMH benchmark, WMDS.netP, ActiveDriver and WMDS.net ranked in the top three tools according to F0.2-measure (<xref rid="btad071-F3" ref-type="fig">Fig. 3D</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S6</xref>). It is not surprising that ActiveDriver performed relatively better in the PMH benchmark than in CGC and NCG benchmarks since some genes in the PMH list were from the predictions of ActiveDriver that potentially favors the performance of ActiveDriver. In addition to better overall performance, our methods also performed consistently better than other tools in most individual tumor types (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figs S4–S6</xref>).</p>
      <p>Although it downplays the importance of precision and overemphasizes the importance of recall, <italic toggle="yes">F</italic>1-measure has been used by some previous tools (<xref rid="btad071-B28" ref-type="bibr">Guo <italic toggle="yes">et al.</italic>, 2019</xref>). Consistently, the relative performance of these prediction tools remained largely unchanged using the <italic toggle="yes">F</italic>1-measure compared to the F0.2-measure; WMDS.netP and WMDS.net are still the best performers among these tools (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S7</xref>). Taken together, these comparisons suggest our method is powerful among various datasets and outperforms the other top-tier tools.</p>
    </sec>
    <sec>
      <title>3.4 Mutation frequency of driver genes predicted by WMDS.net</title>
      <p>‘Long-tail phenomenon’ states that cancer driver genes consist of a small number of frequently mutated genes and a large number of infrequently mutated genes (<xref rid="btad071-B55" ref-type="bibr">Reimand and Bader, 2013</xref>). Discovering driver genes with rare mutation frequency in the long tail of genetic alterations remains challenging. Although WMDS.net identifies cancer driver genes based on transcriptome networks, we can use their somatic mutation data to assess how often these identified driver genes are mutated in tumor samples. To evaluate the ability of WMDS.net to find driver genes of rare mutation, we first obtained somatic SNVs data of 14 cancer datasets from TCGA. Then, the driver genes predicted by WMDS.net that overlap with the CCG gene list were divided into driver genes with low mutation frequency (frequency &lt;0.05) and driver genes with high-mutation frequency (frequency &gt;0.05) according their SNVs data. We calculated the fraction of these two categories of driver genes among 14 types of cancer. As shown in <xref rid="btad071-F4" ref-type="fig">Figure 4</xref>, most driver genes predicted by WMDS.net were rarely mutated among different cancer types, indicating the strong ability of WMDS.net of finding driver genes with low-frequency mutations. Here, we took TCGA LUAD cancer as an example and found that many driver genes with low mutation frequency overlapped with the CCG gene list, but not found by other methods (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>). For example, ‘ERBB3’ was detected as a driver gene by WMDS.net in LUAD, but was not found by other methods. ERBB3 is rarely mutated in LUAD based on the cosmic database (<ext-link xlink:href="https://cancer.sanger.ac.uk" ext-link-type="uri">https://cancer.sanger.ac.uk</ext-link>). ERBB3 encodes a member of the epidermal growth factor receptor family of receptor tyrosine kinases and plays an important role in several cancers (<xref rid="btad071-B21" ref-type="bibr">Gandullo-Sanchez <italic toggle="yes">et al.</italic>, 2022</xref>).</p>
      <fig position="float" id="btad071-F4">
        <label>Fig. 4.</label>
        <caption>
          <p>Fraction of driver genes with low- and high-mutation frequency for 14 types of cancer predicted by WMDS.net in the CCG gene list. Low mutation: somatic mutation frequency &lt;0.05 in tumor samples; high mutation: somatic mutation frequency &gt;0.05 in tumor samples</p>
        </caption>
        <graphic xlink:href="btad071f4" position="float"/>
      </fig>
    </sec>
    <sec>
      <title>3.5 Personalized driver genes predicted by WMDS.net</title>
      <p>We also applied WMDS to the personalized patient-specific networks constructed by SSN (<xref rid="btad071-B46" ref-type="bibr">Liu <italic toggle="yes">et al.</italic>, 2016</xref>) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S2</xref>) to find personalized driver genes for each cancer patient. For a given type of cancer, we defined the high-frequency personalized driver gene that was predicted as a driver in more than 60% of patients in this cancer type (i.e. frequency ≥0.6), the medium-frequency personalized driver gene (0.3≤frequency &lt;0.6) and low-frequency personalized driver gene (frequency &lt;0.3). As shown in <xref rid="btad071-F5" ref-type="fig">Figure 5</xref>, the low-frequency personalized driver genes account for a large proportion of driver genes among all types of cancer. That is, each patient carries its own unique set of cancer driver genes, indicating the unexpectedly high tumor heterogeneity of cancer patients in the same type of cancer. Furthermore, these personalized driver genes were often not detected by methods based on cancer-type-wide gene co-expression networks. For instance, ‘CDKN2A’ was identified as a personalized driver gene in LUAD by WMDS.netP, but not identified by WMDS.net (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S3</xref>). CDKN2A is known to be an important tumor suppressor gene in several cancer including LUAD (<xref rid="btad071-B53" ref-type="bibr">Nahar <italic toggle="yes">et al.</italic>, 2018</xref>).</p>
      <fig position="float" id="btad071-F5">
        <label>Fig. 5.</label>
        <caption>
          <p>Fraction of personal driver genes in 14 cancer data sets. High-frequency personalized drivers are genes predicted as drivers in more than 60% of patients in a cancer type (i.e. with frequency ≥0.6), the medium-frequency personalized drivers with 0.3≤frequency &lt;0.6 and low-frequency personalized drivers with frequency &lt;0.3</p>
        </caption>
        <graphic xlink:href="btad071f5" position="float"/>
      </fig>
    </sec>
    <sec>
      <title>3.6 Running time of WMDS</title>
      <p>The time complexity of computing WMDS is the same as that of MDS. We implemented the WMDS algorithm using Matlab in a workstation with Intel 4 CPU (3.40 GH×4) and 24 GB RAM. For a network with about 10 000 nodes, the algorithm can produce results within 1 min.</p>
    </sec>
  </sec>
  <sec>
    <title>4 Discussion</title>
    <p>Network controllability is a basic concept of control theory, which quantifies the ability of steering a system from any initial state to any final desired state in finite time (<xref rid="btad071-B33" ref-type="bibr">Hu <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btad071-B47" ref-type="bibr">Liu <italic toggle="yes">et al.</italic>, 2011</xref>; <xref rid="btad071-B51" ref-type="bibr">Muller and Schuppert, 2011</xref>). The perturbance of state on one node can influence and change the state of the adjacent nodes through their interactions. A set of nodes that are known as driver nodes can effectively control complex networks through their external input and their intrinsic interactions with neighboring nodes in the network (<xref rid="btad071-B48" ref-type="bibr">Lombardi and Hornquist, 2007</xref>). Therefore, it is of great theoretical and practical significance to study the controllability of complex biological network systems from the perspective of network theory.</p>
    <p>For the transcriptional co-expression network, its network controllability can be interpreted by operating a few key regulators to guide the transcriptional program from one state to another. Finding the key regulators in the transcriptional program can provide key insights into the network state transition underlying cellular phenotypes. To address this challenge, here, we proposed to identify the key regulators in the transcriptional network as a MDS of driver nodes that can fully control the network state transition (<xref rid="btad071-B52" ref-type="bibr">Nacher and Akutsu, 2012</xref>). Based on the theory of structural controllability, we applied a WMDS network model to find the driver nodes of differential co-expression networks (denoted as WMDS.net). The WMDS.net algorithm integrates the degree of nodes in the network and the significance of gene co-expression difference between two physiological states.</p>
    <p>Cancer is a genetic disease that is driven by aberrant genetic and epigenetic changes (<xref rid="btad071-B50" ref-type="bibr">Meyerson <italic toggle="yes">et al.</italic>, 2010</xref>; <xref rid="btad071-B59" ref-type="bibr">Stratton <italic toggle="yes">et al.</italic>, 2009</xref>). During the progression from a normal state to a tumor state, cells often undergo drastic rewiring of the transcription co-expression networks. We applied the WMDS.net to predict key nodes as cancer driver genes that control the state transition of gene co-expression networks in the process of tumorigenesis and cancer progression. A total of 6835 specimens among 14 major types of cancer in TCGA, each of which contained at least 15 normal samples, were used for detecting driver genes. Our comprehensive evaluation demonstrated that genes predicted by WMDS.net are significantly more enriched than other top-tier tools in the CGC, NCG and PMH databases that provide approximate benchmarks for real cancer-associated genes.</p>
    <p>From the perspective of detecting tumor driver genes, WMDS.net provides several advanced features compared with currently existing methods. First, WMDS.net gives a better balance between precision and recall of predicted driver genes. The number of predictions by WMDS.net is moderate, unlike some tools (e.g. iPAC and PNC) that are ambitious to predict too many drivers (e.g. &gt;3000) (<xref rid="btad071-B28" ref-type="bibr">Guo <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btad071-B56" ref-type="bibr">Ryslik <italic toggle="yes">et al.</italic>, 2013</xref>) or other tools (e.g. DriverNet) that are too conservative to predict too few drivers (e.g. &lt;10) (<xref rid="btad071-B5" ref-type="bibr">Bashashati <italic toggle="yes">et al.</italic>, 2012</xref>). It is also worth noting that although both WMDS.net and PNC are network-based methods, the determination of the minimum driving nodes by the PNC algorithm in an undirected network is equivalent to selecting at least one endpoint from each edge with two endpoints in the graph, so that it will result in too many nodes being identified as driver genes (<xref rid="sup1" ref-type="supplementary-material">Supplementary Material</xref>). Second, unlike some tools that only focus on genes with high-mutation rate and thus miss some real driver genes (<xref rid="btad071-B44" ref-type="bibr">Lawrence <italic toggle="yes">et al.</italic>, 2013</xref>; <xref rid="btad071-B63" ref-type="bibr">Tamborero <italic toggle="yes">et al.</italic>, 2013b</xref>), WMDS.net has a strong ability of identifying driver genes with low mutation rate. Third, WMDS.net is also applicable to individualized differential co-expression networks to find personalized cancer drivers for individual cancer patients. Notably, the personalized cancer driver genes of different patients are quite different, indicating the high tumor heterogeneity of cancer patients in the same type of cancer. The discovery of cancer driver genes at both the population and individual levels will not only fundamentally improve the understanding of carcinogenesis, tumor promotion and progression, but also inform potential therapies targeted against dysregulation of driver genes.</p>
    <p>Several caveats for our study should be acknowledged. First, WMDS.net is based on the collected known molecular interaction networks. Such networks are usually incomplete with some unknown or questionable interactions, and they are also not tissue-specific, which may lead to inaccurate prediction of the key regulators that are really involved in context-dependent transcriptional regulation. However, we verified that our method of constructing differential co-expression network is robust and stable for different sample sizes (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S1</xref>). Taking BRCA as an example, 35, 40 and 45 tumor samples were used to construct differential co-expression networks. Compared with the 40-sample network, the edges recurrence rates of 35- and 45-sample networks were 94.67% and 96.20%, respectively. Second, WMDS.net is based on undirected co-expression networks and only utilizes the expression alteration information of genes and the relationship between them; however, this may not be true for all biological networks. The WMDS model provides approximate equivalence to the structural controllability theory when the edges of the MDS are bi-directional. In the future, it is worth studying how to integrate directed biological information, such as transcription factor regulation (e.g. non-linear dynamics and negative feedback loop) and network topology information to discover a complete catalog of key regulators that can steer a complex biological system from normal state to pathological state or <italic toggle="yes">vice versa</italic>. Finally, our method tended to select the MDS with members having the highest degree and most significant difference of co-expression correlation in a given network. There are also many examples in which driver nodes are not hubs in a network (<xref rid="btad071-B47" ref-type="bibr">Liu <italic toggle="yes">et al.</italic>, 2011</xref>). Although our method facilitates the detection of driver nodes with high connectivity, it may miss the detection of non-hub driver nodes in gene co-expression networks.</p>
    <p>In summary, WMDS.net is an innovative network control tool for identifying driver nodes that can guide the state transition of transcriptional co-expression network. It helps to reveal the key regulators of cellular processes in both physiological and pathological states. To confirm its validity, we applied WMDS.net to the discovery of cancer driver genes in TCGA RNA-seq datasets. WMDS.net is powerful among various cancer datasets and outperformed the other top-tier tools with a better balance between precision and recall.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btad071_Supplementary_Data</label>
      <media xlink:href="btad071_supplementary_data.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>We thank the Genomic Data Commons for providing access to TCGA RNA-seq data. We thank Ms Chao Bi at the Core Facility of Zhejiang University School of Medicine for providing technical support, Dr Christopher R. Wood for English grammar polishing and anonymous reviewers for reading and commenting on the manuscript.</p>
  </ack>
  <sec>
    <title>Authors’ contributions</title>
    <p>Y.L. and P.L. considered and designed the study. X.C. developed the algorithm and performed the data analysis. M.A., W.L., Y.L. and X.P. discussed and commented the algorithm and data analysis. X.C., Y.L. and P.L. wrote the manuscript. P.L., Y.L., H.X. and H.Z. revised the manuscript. All of the authors approved the study.</p>
  </sec>
  <sec>
    <title>Funding</title>
    <p>This work was supported in part by the Key Research &amp; Development Program of Zhejiang Province [2021C03126]; the National Natural Science Foundation of China [82072857, 81871864, 92253203]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2019-I2M-5-044]; Medical Health Science and Technology Key Project of Zhejiang Provincial Health Commission [WKJ-ZJ-2007]; the Key Program of Zhejiang Provincial Natural Science Foundation [LZ20H160001]; and the National Institutes of Health (HL149620).</p>
    <p><italic toggle="yes">Conflict of Interest</italic>: none declared.</p>
  </sec>
  <sec sec-type="data-availability">
    <title>Data availability</title>
    <p>The source codes for implementing WMDS.net are deposited at <ext-link xlink:href="https://github.com/chaofen123/WMDS.net" ext-link-type="uri">https://github.com/chaofen123/WMDS.net</ext-link>.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btad071-B1">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Achanta</surname><given-names>R.</given-names></string-name></person-group><etal>et al</etal> (<year>2009</year>) Frequency-tuned salient region detection. In: <italic toggle="yes">CVPR: 2009 IEEE Conference on Computer Vision and Pattern Recognition</italic>, <italic toggle="yes">Miami, FL, USA</italic>, Vol. 1–4, pp. <fpage>1597</fpage>–<lpage>1604</lpage>.</mixed-citation>
    </ref>
    <ref id="btad071-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bakhteh</surname><given-names>S.</given-names></string-name></person-group><etal>et al</etal> (<year>2020</year>) <article-title>Identification of minimum set of master regulatory genes in gene regulatory networks</article-title>. <source>IEEE/ACM Trans. Comput. Biol. Bioinform</source>., <volume>17</volume>, <fpage>999</fpage>–<lpage>1009</lpage>.<pub-id pub-id-type="pmid">30334767</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barabasi</surname><given-names>A.L.</given-names></string-name>, <string-name><surname>Albert</surname><given-names>R.</given-names></string-name></person-group> (<year>1999</year>) <article-title>Emergence of scaling in random networks</article-title>. <source>Science</source>, <volume>286</volume>, <fpage>509</fpage>–<lpage>512</lpage>.<pub-id pub-id-type="pmid">10521342</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barabasi</surname><given-names>A.L.</given-names></string-name></person-group><etal>et al</etal> (<year>2011</year>) <article-title>Network medicine: a network-based approach to human disease</article-title>. <source>Nat. Rev. Genet</source>., <volume>12</volume>, <fpage>56</fpage>–<lpage>68</lpage>.<pub-id pub-id-type="pmid">21164525</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bashashati</surname><given-names>A.</given-names></string-name></person-group><etal>et al</etal> (<year>2012</year>) <article-title>DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer</article-title>. <source>Genome Biol</source>., <volume>13</volume>, <fpage>R124</fpage>.<pub-id pub-id-type="pmid">23383675</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Basso</surname><given-names>K.</given-names></string-name></person-group><etal>et al</etal> (<year>2005</year>) <article-title>Reverse engineering of regulatory networks in human B cells</article-title>. <source>Nat. Genet</source>., <volume>37</volume>, <fpage>382</fpage>–<lpage>390</lpage>.<pub-id pub-id-type="pmid">15778709</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bhuva</surname><given-names>D.D.</given-names></string-name></person-group><etal>et al</etal> (<year>2019</year>) <article-title>Differential co-expression-based detection of conditional relationships in transcriptional data: comparative analysis and application to breast cancer</article-title>. <source>Genome Biol</source>., <volume>20</volume>, <fpage>236</fpage>.<pub-id pub-id-type="pmid">31727119</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cheng</surname><given-names>M.M.</given-names></string-name></person-group><etal>et al</etal> (<year>2015</year>) <article-title>Global contrast based salient region detection</article-title>. <source>IEEE Trans. Pattern Anal. Mach. Intell</source>., <volume>37</volume>, <fpage>569</fpage>–<lpage>582</lpage>.<pub-id pub-id-type="pmid">26353262</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chung</surname><given-names>I.-F.</given-names></string-name></person-group><etal>et al</etal> (<year>2016</year>) <article-title>DriverDBv2: a database for human cancer driver gene research</article-title>. <source>Nucleic Acids Res</source>., <volume>44</volume>, <fpage>D975</fpage>–<lpage>D979</lpage>.<pub-id pub-id-type="pmid">26635391</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ciriello</surname><given-names>G.</given-names></string-name></person-group><etal>et al</etal> (<year>2012</year>) <article-title>Mutual exclusivity analysis identifies oncogenic network modules</article-title>. <source>Genome Res</source>., <volume>22</volume>, <fpage>398</fpage>–<lpage>406</lpage>.<pub-id pub-id-type="pmid">21908773</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Croft</surname><given-names>D.</given-names></string-name></person-group><etal>et al</etal> (<year>2011</year>) <article-title>Reactome: a database of reactions, pathways and biological processes</article-title>. <source>Nucleic Acids Res</source>., <volume>39</volume>, <fpage>D691</fpage>–<lpage>D697</lpage>.<pub-id pub-id-type="pmid">21067998</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>D'Antonio</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ciccarelli</surname><given-names>F.D.</given-names></string-name></person-group> (<year>2013</year>) <article-title>Integrated analysis of recurrent properties of cancer genes to identify novel drivers</article-title>. <source>Genome Biol</source>., <volume>14</volume>, <fpage>R52</fpage>.<pub-id pub-id-type="pmid">23718799</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de Anda-Jáuregui</surname><given-names>G.</given-names></string-name></person-group><etal>et al</etal> (<year>2019</year>) <article-title>Functional and transcriptional connectivity of communities in breast cancer co-expression networks</article-title>. <source>Appl. Netw. Sci</source>., <volume>4</volume>, <fpage>22</fpage>.</mixed-citation>
    </ref>
    <ref id="btad071-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de la Fuente</surname><given-names>A.</given-names></string-name></person-group> (<year>2010</year>) <article-title>From ‘differential expression’ to ‘differential networking’ - identification of dysfunctional regulatory networks in diseases</article-title>. <source>Trends Genet</source>., <volume>26</volume>, <fpage>326</fpage>–<lpage>333</lpage>.<pub-id pub-id-type="pmid">20570387</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dees</surname><given-names>N.D.</given-names></string-name></person-group><etal>et al</etal> (<year>2012</year>) <article-title>MuSiC: identifying mutational significance in cancer genomes</article-title>. <source>Genome Res</source>., <volume>22</volume>, <fpage>1589</fpage>–<lpage>1598</lpage>.<pub-id pub-id-type="pmid">22759861</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Delgado</surname><given-names>F.M.</given-names></string-name>, <string-name><surname>Gómez-Vela</surname><given-names>F.</given-names></string-name></person-group> (<year>2019</year>) <article-title>Computational methods for gene regulatory networks reconstruction and analysis: a review</article-title>. <source>Artif. Intell. Med</source>., <volume>95</volume>, <fpage>133</fpage>–<lpage>145</lpage>.<pub-id pub-id-type="pmid">30420244</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Deng</surname><given-names>S.P.</given-names></string-name></person-group><etal>et al</etal> (<year>2015</year>) <article-title>Mining the bladder cancer-associated genes by an integrated strategy for the construction and analysis of differential co-expression networks</article-title>. <source>BMC Genomics</source>, <volume>16 (Suppl. 3)</volume>, <fpage>S4</fpage>.</mixed-citation>
    </ref>
    <ref id="btad071-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eisenberg</surname><given-names>D.</given-names></string-name></person-group><etal>et al</etal> (<year>2000</year>) <article-title>Protein function in the post-genomic era</article-title>. <source>Nature</source>, <volume>405</volume>, <fpage>823</fpage>–<lpage>826</lpage>.<pub-id pub-id-type="pmid">10866208</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fisher</surname><given-names>R.A.</given-names></string-name></person-group> (<year>1915</year>) <article-title>Frequency distribution of the values of the correlation coefficient in samples from an indefinitely large population</article-title>. <source>Biometrika</source>, <volume>10</volume>, <fpage>507</fpage>–<lpage>521</lpage>.</mixed-citation>
    </ref>
    <ref id="btad071-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Flintoft</surname><given-names>L.</given-names></string-name></person-group> (<year>2004</year>) <article-title>Rewiring the network</article-title>. <source>Nat. Rev. Genet</source>., <volume>5</volume>, <fpage>808</fpage>.</mixed-citation>
    </ref>
    <ref id="btad071-B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gandullo-Sanchez</surname><given-names>L.</given-names></string-name></person-group><etal>et al</etal> (<year>2022</year>) <article-title>HER3 in cancer: from the bench to the bedside</article-title>. <source>J. Exp. Clin. Cancer Res</source>., <volume>41</volume>, <fpage>310</fpage>.<pub-id pub-id-type="pmid">36271429</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B22">
      <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Garey</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Johnson</surname><given-names>D.S.</given-names></string-name></person-group> (<year>1990</year>) <source>Computers and Intractability: A Guide to the Theory of NP-Completeness</source>. <publisher-name>W. H. Freeman &amp; Co</publisher-name>., <publisher-loc>New York</publisher-loc>.</mixed-citation>
    </ref>
    <ref id="btad071-B23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Golub</surname><given-names>T.R.</given-names></string-name></person-group><etal>et al</etal> (<year>1999</year>) <article-title>Molecular classification of cancer: class discovery and class prediction by gene expression monitoring</article-title>. <source>Science</source>, <volume>286</volume>, <fpage>531</fpage>–<lpage>537</lpage>.<pub-id pub-id-type="pmid">10521349</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gonzalez-Perez</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lopez-Bigas</surname><given-names>N.</given-names></string-name></person-group> (<year>2012</year>) <article-title>Functional impact bias reveals cancer drivers</article-title>. <source>Nucleic Acids Res</source>., <volume>40</volume>, <fpage>e169</fpage>.<pub-id pub-id-type="pmid">22904074</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B25">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Grechkin</surname><given-names>M.</given-names></string-name></person-group><etal>et al</etal> (<year>2016</year>) <article-title>Identifying network perturbation in cancer</article-title>. <source>PLoS Comput. Biol</source>., <volume>12</volume>, <fpage>e1004888</fpage>.<pub-id pub-id-type="pmid">27145341</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B26">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Greenman</surname><given-names>C.</given-names></string-name></person-group><etal>et al</etal> (<year>2007</year>) <article-title>Patterns of somatic mutation in human cancer genomes</article-title>. <source>Nature</source>, <volume>446</volume>, <fpage>153</fpage>–<lpage>158</lpage>.<pub-id pub-id-type="pmid">17344846</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B27">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guo</surname><given-names>W.F.</given-names></string-name></person-group><etal>et al</etal> (<year>2018</year>) <article-title>Discovering personalized driver mutation profiles of single samples in cancer by network control strategy</article-title>. <source>Bioinformatics</source>, <volume>34</volume>, <fpage>1893</fpage>–<lpage>1903</lpage>.<pub-id pub-id-type="pmid">29329368</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B28">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guo</surname><given-names>W.F.</given-names></string-name></person-group><etal>et al</etal> (<year>2019</year>) <article-title>A novel network control model for identifying personalized driver genes in cancer</article-title>. <source>PLoS Comput. Biol</source>., <volume>15</volume>, <fpage>e1007520</fpage>.<pub-id pub-id-type="pmid">31765387</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B29">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gustafsson</surname><given-names>M.</given-names></string-name></person-group><etal>et al</etal> (<year>2014</year>) <article-title>Modules, networks and systems medicine for understanding disease and aiding diagnosis</article-title>. <source>Genome Med</source>., <volume>6</volume>, <fpage>82</fpage>.<pub-id pub-id-type="pmid">25473422</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B30">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Han</surname><given-names>Y.</given-names></string-name></person-group><etal>et al</etal> (<year>2019</year>) <article-title>DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies</article-title>. <source>Nucleic Acids Res</source>., <volume>47</volume>, <fpage>e45</fpage>.<pub-id pub-id-type="pmid">30773592</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B31">
      <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Haynes</surname><given-names>T.W.</given-names></string-name></person-group><etal>et al</etal> (<year>1998</year>) <source>Fundamentals of Domination in Graphs</source>. <publisher-name>Pure Applied Mathematics</publisher-name>, <publisher-loc>New York</publisher-loc>.</mixed-citation>
    </ref>
    <ref id="btad071-B32">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hou</surname><given-names>J.P.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>J.</given-names></string-name></person-group> (<year>2014</year>) <article-title>DawnRank: discovering personalized driver genes in cancer</article-title>. <source>Genome Med</source>., <volume>6</volume>, <fpage>56</fpage>.<pub-id pub-id-type="pmid">25177370</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B33">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hu</surname><given-names>Y.X.</given-names></string-name></person-group><etal>et al</etal> (<year>2019</year>) <article-title>Optimal control nodes in disease-perturbed networks as targets for combination therapy</article-title>. <source>Nat. Commun</source>., <volume>10</volume>, <fpage>2180</fpage>.<pub-id pub-id-type="pmid">31097707</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B34">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hua</surname><given-names>X.</given-names></string-name></person-group><etal>et al</etal> (<year>2013</year>) <article-title>DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies</article-title>. <source>Am. J. Hum. Genet</source>., <volume>93</volume>, <fpage>439</fpage>–<lpage>451</lpage>.<pub-id pub-id-type="pmid">23954162</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B35">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>P.</given-names></string-name></person-group><etal>et al</etal> (<year>2011</year>) <article-title>Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors</article-title>. <source>Nature</source>, <volume>475</volume>, <fpage>386</fpage>–<lpage>389</lpage>.<pub-id pub-id-type="pmid">21562492</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B36">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ideker</surname><given-names>T.</given-names></string-name>, <string-name><surname>Krogan</surname><given-names>N.J.</given-names></string-name></person-group> (<year>2012</year>) <article-title>Differential network biology</article-title>. <source>Mol. Syst. Biol</source>., <volume>8</volume>, <fpage>565</fpage>.<pub-id pub-id-type="pmid">22252388</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B37">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ieda</surname><given-names>M.</given-names></string-name></person-group><etal>et al</etal> (<year>2010</year>) <article-title>Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors</article-title>. <source>Cell</source>, <volume>142</volume>, <fpage>375</fpage>–<lpage>386</lpage>.<pub-id pub-id-type="pmid">20691899</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B38">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jia</surname><given-names>P.L.</given-names></string-name></person-group><etal>et al</etal> (<year>2014</year>) <article-title>MSEA: detection and quantification of mutation hotspots through mutation set enrichment analysis</article-title>. <source>Genome Biol</source>., <volume>15</volume>, <fpage>489</fpage>.<pub-id pub-id-type="pmid">25348067</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B39">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kanehisa</surname><given-names>M.</given-names></string-name></person-group><etal>et al</etal> (<year>2012</year>) <article-title>KEGG for integration and interpretation of large-scale molecular data sets</article-title>. <source>Nucleic Acids Res</source>., <volume>40</volume>, <fpage>D109</fpage>–<lpage>D114</lpage>.<pub-id pub-id-type="pmid">22080510</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B40">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Khurana</surname><given-names>E.</given-names></string-name></person-group><etal>et al</etal>; <collab>1000 Genomes Project Consortium</collab>. (<year>2013</year>) <article-title>Integrative annotation of variants from 1092 humans: application to cancer genomics</article-title>. <source>Science</source>, <volume>342</volume>, <fpage>1235587</fpage>.<pub-id pub-id-type="pmid">24092746</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B41">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kumar</surname><given-names>R.D.</given-names></string-name></person-group><etal>et al</etal> (<year>2015</year>) <article-title>Statistically identifying tumor suppressors and oncogenes from pan-cancer genome-sequencing data</article-title>. <source>Bioinformatics</source>, <volume>31</volume>, <fpage>3561</fpage>–<lpage>3568</lpage>.<pub-id pub-id-type="pmid">26209800</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B42">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kuzmanovski</surname><given-names>V.</given-names></string-name></person-group><etal>et al</etal> (<year>2018</year>) <article-title>Extensive evaluation of the generalized relevance network approach to inferring gene regulatory networks</article-title>. <source>Gigascience</source>, <volume>7</volume>, <fpage>giy118</fpage>.<pub-id pub-id-type="pmid">30239704</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B43">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Langfelder</surname><given-names>P.</given-names></string-name>, <string-name><surname>Horvath</surname><given-names>S.</given-names></string-name></person-group> (<year>2008</year>) <article-title>WGCNA: an R package for weighted correlation network analysis</article-title>. <source>BMC Bioinformatics</source>, <volume>9</volume>, <fpage>559</fpage>.<pub-id pub-id-type="pmid">19114008</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B44">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lawrence</surname><given-names>M.S.</given-names></string-name></person-group><etal>et al</etal> (<year>2013</year>) <article-title>Mutational heterogeneity in cancer and the search for new cancer-associated genes</article-title>. <source>Nature</source>, <volume>499</volume>, <fpage>214</fpage>–<lpage>218</lpage>.<pub-id pub-id-type="pmid">23770567</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B45">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lin</surname><given-names>C.C.</given-names></string-name></person-group><etal>et al</etal> (<year>2015</year>) <article-title>A cross-cancer differential co-expression network reveals microRNA-regulated oncogenic functional modules</article-title>. <source>Mol. Biosyst</source>., <volume>11</volume>, <fpage>3244</fpage>–<lpage>3252</lpage>.<pub-id pub-id-type="pmid">26448606</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B46">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>X.P.</given-names></string-name></person-group><etal>et al</etal> (<year>2016</year>) <article-title>Personalized characterization of diseases using sample-specific networks</article-title>. <source>Nucleic Acids Res</source>., <volume>44</volume>, <fpage>e164</fpage>.<pub-id pub-id-type="pmid">27596597</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B47">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>Y.Y.</given-names></string-name></person-group><etal>et al</etal> (<year>2011</year>) <article-title>Controllability of complex networks</article-title>. <source>Nature</source>, <volume>473</volume>, <fpage>167</fpage>–<lpage>173</lpage>.<pub-id pub-id-type="pmid">21562557</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B48">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lombardi</surname><given-names>A.</given-names></string-name>, <string-name><surname>Hornquist</surname><given-names>M.</given-names></string-name></person-group> (<year>2007</year>) <article-title>Controllability analysis of networks</article-title>. <source>Phys. Rev. E Stat. Nonlin. Soft. Matter Phys</source>., <volume>75</volume>, <fpage>056110</fpage>.<pub-id pub-id-type="pmid">17677136</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B49">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lu</surname><given-names>X.</given-names></string-name></person-group><etal>et al</etal> (<year>2007</year>) <article-title>Hubs in biological interaction networks exhibit low changes in expression in experimental asthma</article-title>. <source>Mol. Syst. Biol</source>., <volume>3</volume>, <fpage>98</fpage>.<pub-id pub-id-type="pmid">17437023</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B50">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meyerson</surname><given-names>M.</given-names></string-name></person-group><etal>et al</etal> (<year>2010</year>) <article-title>Advances in understanding cancer genomes through second-generation sequencing</article-title>. <source>Nat. Rev. Genet</source>., <volume>11</volume>, <fpage>685</fpage>–<lpage>696</lpage>.<pub-id pub-id-type="pmid">20847746</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B51">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Muller</surname><given-names>F.J.</given-names></string-name>, <string-name><surname>Schuppert</surname><given-names>A.</given-names></string-name></person-group> (<year>2011</year>) <article-title>Few inputs can reprogram biological networks</article-title>. <source>Nature</source>, <volume>478</volume>, <fpage>E4</fpage>.<pub-id pub-id-type="pmid">22012402</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B52">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nacher</surname><given-names>J.C.</given-names></string-name>, <string-name><surname>Akutsu</surname><given-names>T.</given-names></string-name></person-group> (<year>2012</year>) <article-title>Dominating scale-free networks with variable scaling exponent: heterogeneous networks are not difficult to control</article-title>. <source>New J. Phys</source>., <volume>14</volume>, <fpage>073005</fpage>.</mixed-citation>
    </ref>
    <ref id="btad071-B53">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nahar</surname><given-names>R.</given-names></string-name></person-group><etal>et al</etal> (<year>2018</year>) <article-title>Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing</article-title>. <source>Nat. Commun</source>., <volume>9</volume>, <fpage>216</fpage>.<pub-id pub-id-type="pmid">29335443</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B54">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Perazzi</surname><given-names>F.</given-names></string-name></person-group><etal>et al</etal> (<year>2012</year>) Saliency filters: contrast based filtering for salient region detection. In: <italic toggle="yes">2012 IEEE Conference on Computer Vision and Pattern Recognition</italic>, <italic toggle="yes">Providence, RL, USA</italic>, pp. <fpage>733</fpage>–<lpage>740</lpage>.</mixed-citation>
    </ref>
    <ref id="btad071-B55">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Reimand</surname><given-names>J.</given-names></string-name>, <string-name><surname>Bader</surname><given-names>G.D.</given-names></string-name></person-group> (<year>2013</year>) <article-title>Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers</article-title>. <source>Mol. Syst. Biol</source>., <volume>9</volume>, <fpage>637</fpage>.<pub-id pub-id-type="pmid">23340843</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B56">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ryslik</surname><given-names>G.A.</given-names></string-name></person-group><etal>et al</etal> (<year>2013</year>) <article-title>Utilizing protein structure to identify non-random somatic mutations</article-title>. <source>BMC Bioinformatics</source>, <volume>14</volume>, <fpage>190</fpage>.<pub-id pub-id-type="pmid">23758891</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B57">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schaefer</surname><given-names>C.F.</given-names></string-name></person-group><etal>et al</etal> (<year>2009</year>) <article-title>PID: the pathway interaction database</article-title>. <source>Nucleic Acids Res</source>., <volume>37</volume>, <fpage>D674</fpage>–<lpage>D679</lpage>.<pub-id pub-id-type="pmid">18832364</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B58">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schaefer</surname><given-names>M.H.</given-names></string-name></person-group><etal>et al</etal> (<year>2015</year>) <article-title>Correcting for the study bias associated with protein-protein interaction measurements reveals differences between protein degree distributions from different cancer types</article-title>. <source>Front. Genet</source>., <volume>6</volume>, <fpage>260</fpage>.<pub-id pub-id-type="pmid">26300911</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B59">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stratton</surname><given-names>M.R.</given-names></string-name></person-group><etal>et al</etal> (<year>2009</year>) <article-title>The cancer genome</article-title>. <source>Nature</source>, <volume>458</volume>, <fpage>719</fpage>–<lpage>724</lpage>.<pub-id pub-id-type="pmid">19360079</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B60">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Szabo</surname><given-names>E.</given-names></string-name></person-group><etal>et al</etal> (<year>2010</year>) <article-title>Direct conversion of human fibroblasts to multilineage blood progenitors</article-title>. <source>Nature</source>, <volume>468</volume>, <fpage>521</fpage>–<lpage>526</lpage>.<pub-id pub-id-type="pmid">21057492</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B61">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Takahashi</surname><given-names>K.</given-names></string-name>, <string-name><surname>Yamanaka</surname><given-names>S.</given-names></string-name></person-group> (<year>2006</year>) <article-title>Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors</article-title>. <source>Cell</source>, <volume>126</volume>, <fpage>663</fpage>–<lpage>676</lpage>.<pub-id pub-id-type="pmid">16904174</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B62">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tamborero</surname><given-names>D.</given-names></string-name></person-group><etal>et al</etal> (<year>2013a</year>) Comprehensive identification of mutational cancer driver genes across 12 tumor types. <italic toggle="yes">Sci. Rep.</italic>, <bold>3</bold>, 2650.</mixed-citation>
    </ref>
    <ref id="btad071-B63">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tamborero</surname><given-names>D.</given-names></string-name></person-group><etal>et al</etal> (<year>2013b</year>) OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes. <italic toggle="yes">Bioinformatics</italic>, <bold>29</bold>, <fpage>2238</fpage>–<lpage>2244</lpage>.</mixed-citation>
    </ref>
    <ref id="btad071-B64">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Torres</surname><given-names>D.J.</given-names></string-name></person-group> (<year>2020</year>) <article-title>Describing the Pearson R distribution of aggregate data</article-title>. <source>Monte Carlo Methods Appl</source>., <volume>26</volume>, <fpage>17</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">32139979</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B65">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>van Noort</surname><given-names>V.</given-names></string-name></person-group><etal>et al</etal> (<year>2004</year>) <article-title>The yeast coexpression network has a small-world, scale-free architecture and can be explained by a simple model</article-title>. <source>EMBO Rep</source>., <volume>5</volume>, <fpage>280</fpage>–<lpage>284</lpage>.<pub-id pub-id-type="pmid">14968131</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B66">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vierbuchen</surname><given-names>T.</given-names></string-name></person-group><etal>et al</etal> (<year>2010</year>) <article-title>Direct conversion of fibroblasts to functional neurons by defined factors</article-title>. <source>Nature</source>, <volume>463</volume>, <fpage>1035</fpage>–<lpage>1041</lpage>.<pub-id pub-id-type="pmid">20107439</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B67">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vogelstein</surname><given-names>B.</given-names></string-name></person-group><etal>et al</etal> (<year>2013</year>) <article-title>Cancer genome landscapes</article-title>. <source>Science</source>, <volume>339</volume>, <fpage>1546</fpage>–<lpage>1558</lpage>.<pub-id pub-id-type="pmid">23539594</pub-id></mixed-citation>
    </ref>
    <ref id="btad071-B68">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>B.</given-names></string-name>, <string-name><surname>Horvath</surname><given-names>S.</given-names></string-name></person-group> (<year>2005</year>) <article-title>A general framework for weighted gene co-expression network analysis</article-title>. <source>Stat. Appl. Genet. Mol. Biol</source>., <volume>4</volume>, <fpage>17</fpage>.</mixed-citation>
    </ref>
    <ref id="btad071-B69">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>X.F.</given-names></string-name></person-group><etal>et al</etal> (<year>2015</year>) <article-title>Determining minimum set of driver nodes in protein-protein interaction networks</article-title>. <source>BMC Bioinformatics</source>, <volume>16</volume>, <fpage>146</fpage>.<pub-id pub-id-type="pmid">25947063</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
